3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
3
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Kidney Neoplasms
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
Carboplatin
123
pembrolizumab
122
Pemetrexed
104
Cisplatin
78
Paclitaxel
56
osimertinib
52
Nivolumab
50
Docetaxel
50
durvalumab
47
Specimen Handling
37
Gemcitabine
34
Magnetic Resonance Spectroscopy
33
Radiosurgery
27
atezolizumab
26
Cetuximab
26
130-nm albumin-bound paclitaxel
26
Radiotherapy
20
Ipilimumab
19
Drug Therapy
19
Bevacizumab
19
cemiplimab
17
amivantamab
17
Taxes
16
Ramucirumab
13
tislelizumab
12
alectinib
12
lazertinib
11
Leucovorin
11
Fluorouracil
11
Radiation
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Non-Small-Cell Lung
×
Biopsy, Large-Core Needle
×
90 days
×
Clear all
NCT05520099
2026-04-29
ELEPHAS-02
Elephas
Active not recruiting
416 enrolled